Correction: Chemical synthesis, bioinformatics and antiproliferative studies of novel pyrimidin-4-yl-1H-pyrazole derivatives in chronic myeloid cancer cells | Synapse
March 3, 2026Open Access
Correction: Chemical synthesis, bioinformatics and antiproliferative studies of novel pyrimidin-4-yl-1H-pyrazole derivatives in chronic myeloid cancer cells
Key Points
Novel pyrimidin-4-yl-1H-pyrazole derivatives exhibit significant antiproliferative activity against chronic myeloid cancer cells,
This study demonstrates the role of bioinformatics in identifying promising chemical compounds for cancer treatment.
Chemical synthesis methods successfully generated derivatives that could aid in developing effective therapies for chronic myeloid cancer.
Findings indicate a new pathway for exploring cancer treatments based on these synthesized compounds.